Pharsight

1. List of Cycloset drug patents

Patent Number	Company	Patent Title	Patent Expiry
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8137992	VEROSCIENCE	Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof	Jul, 2023 (a month from now)
US8137994	VEROSCIENCE	Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof	Jul, 2023 (a month from now)
US8137993	VEROSCIENCE	Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof	Jul, 2023 (a month from now)
US7888310	VEROSCIENCE	Methods of identifying responders to dopamine agonist therapy	Jul, 2023 (a month from now)
US9895422	VEROSCIENCE	Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders	Jun, 2030 (7 years from now)
US9352025	VEROSCIENCE	Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders	Jun, 2030 (7 years from now)
US10688155	VEROSCIENCE	Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders	Jun, 2030 (7 years from now)
US8877708	VEROSCIENCE	Combination of dopamine agonists plus first phase secretagogues for the treatment of metabolic disorders	Jun, 2030 (7 years from now)
US8613947	VEROSCIENCE	Bromocriptine formulations	Apr, 2032 (8 years from now)
US9700555	VEROSCIENCE	Bromocriptine formulations	Apr, 2032 (8 years from now)
US9993474	VEROSCIENCE	Bromocriptine formulations	Apr, 2032 (8 years from now)
US9192576	VEROSCIENCE	Bromocriptine formulations	Apr, 2032 (8 years from now)
US9522117	VEROSCIENCE	Bromocriptine formulations	Apr, 2032 (8 years from now)
US10688094	VEROSCIENCE	Bromocriptine formulations	Apr, 2032 (8 years from now)
US11000522	VEROSCIENCE	Bromocriptine formulations	Apr, 2032 (8 years from now)
US8431155	VEROSCIENCE	Bromocriptine formulations	Apr, 2032 (8 years from now)

Do you want to check out CYCLOSET patents from before 2022?

Drugs and Companies using BROMOCRIPTINE MESYLATE ingredient

Market Authorisation Date: 05 May, 2009

Treatment: Improvements of glycemic control in individuals with type 2 diabetes who have one or more specified cardiovascular risk factors; Adjunct to diet and exercise to improve glycemic control in adults with...

Dosage: TABLET;ORAL